145 related articles for article (PubMed ID: 38741777)
1. Association of body mass index with clinical outcome of primary WHO grade 4 glioma.
Wang J; Hao Z; Li R; Wu W; Huang N; Zhang K; Hao S; Feng J; Chu J; Ji N
Front Oncol; 2024; 14():1318785. PubMed ID: 38741777
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer.
Van Baelen K; Nguyen HL; Hamy-Petit AS; Richard F; Karsten MM; Nader Marta G; Vermeulen P; Toussaint A; Reyal F; Vincent-Salomon A; Dirix L; Dordevic AD; de Azambuja E; Larsimont D; Amato O; Maetens M; De Schepper M; Geukens T; Han SN; Baert T; Punie K; Wildiers H; Smeets A; Nevelsteen I; Floris G; Biganzoli E; Neven P; Desmedt C
Eur J Cancer; 2023 Sep; 191():112988. PubMed ID: 37573673
[TBL] [Abstract][Full Text] [Related]
4. Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition.
Naik GS; Waikar SS; Johnson AEW; Buchbinder EI; Haq R; Hodi FS; Schoenfeld JD; Ott PA
J Immunother Cancer; 2019 Mar; 7(1):89. PubMed ID: 30922394
[TBL] [Abstract][Full Text] [Related]
5. Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma.
Zhao TC; Liang SY; Ju WT; Liu Y; Tan YR; Zhu DW; Zhang CP; Zhang ZY; Zhong LP
Clin Nutr; 2020 Sep; 39(9):2751-2758. PubMed ID: 31839432
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
7. The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysis.
Huang SY; Su PJ; Lin CT; Kuo MC; Chen YH; Wu CC; Luo HL; Chen CH; Chou CC; Huang CC; Kuo CW; Su YL
Cancer Med; 2024 Jan; 13(2):e7008. PubMed ID: 38334504
[TBL] [Abstract][Full Text] [Related]
8. A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials.
Li LX; Socinski MA; Kichenadasse G; Karapetis CS; Shahnam A; McKinnon RA; Rowland A; Hopkins AM; Sorich MJ
BMC Cancer; 2024 Mar; 24(1):379. PubMed ID: 38528478
[TBL] [Abstract][Full Text] [Related]
9. Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.
Ghinda D; Zhang N; Lu J; Yao CJ; Yuan S; Wu JS
Neurosurg Focus; 2016 Mar; 40(3):E14. PubMed ID: 26926054
[TBL] [Abstract][Full Text] [Related]
10. Body mass index as an independent prognostic factor in glioblastoma.
Valente Aguiar P; Carvalho B; Vaz R; Linhares P
Cancer Causes Control; 2021 Apr; 32(4):327-336. PubMed ID: 33447892
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
12. Impact of body mass index on pathological complete response and survival of breast cancer patients receiving neoadjuvant chemotherapy.
Aguiar D; Ros L; Pérez D; Croissier L; Mori M; Hernández M; Vargas AM; Galván S; Antonilli C; Saura S
Breast Dis; 2022; 41(1):351-361. PubMed ID: 36031886
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic body weight and survival in high grade glioma.
Siegel EM; Nabors LB; Thompson RC; Olson JJ; Browning JE; Madden MH; Han G; Egan KM
J Neurooncol; 2013 Aug; 114(1):79-84. PubMed ID: 23666204
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and glioma risk: A prospective multicenter study.
Shao C; Tang H; Wang X; He J; Wang P; Wu N
Front Endocrinol (Lausanne); 2022; 13():933921. PubMed ID: 36105407
[TBL] [Abstract][Full Text] [Related]
15. The impact of baseline body mass index on clinical outcomes in metastatic breast cancer: a prospective study.
Alarfi H; Salamoon M; Kadri M; Alammar M; Haykal MA; Alseoudi A; Youssef LA
BMC Res Notes; 2017 Nov; 10(1):550. PubMed ID: 29096707
[TBL] [Abstract][Full Text] [Related]
16. The impact of body weight on ovarian cancer outcomes.
Backes FJ; Nagel CI; Bussewitz E; Donner J; Hade E; Salani R
Int J Gynecol Cancer; 2011 Dec; 21(9):1601-5. PubMed ID: 21997171
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
18. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
19. The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study.
Wiedmann MKH; Brunborg C; Di Ieva A; Lindemann K; Johannesen TB; Vatten L; Helseth E; Zwart JA
Neuro Oncol; 2017 Jul; 19(7):976-985. PubMed ID: 28040713
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram.
He Q; Li L; Ren Q
Front Oncol; 2021; 11():671811. PubMed ID: 34055639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
